Although our findings are promising, a further validation of CD8-positive NK cells as a potential biomarker for TNF responsiveness is necessary in an independent cohort of AS and other rheumatic and gastrointestinal diseases where anti-TNF blockers are successfully administered. Here, TNF is linked to gastrointestinal disease.